![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TPD52L1 |
Gene summary for TPD52L1 |
![]() |
Gene information | Species | Human | Gene symbol | TPD52L1 | Gene ID | 7164 |
Gene name | TPD52 like 1 | |
Gene Alias | D53 | |
Cytomap | 6q22.31 | |
Gene Type | protein-coding | GO ID | GO:0000086 | UniProtAcc | Q15730 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
7164 | TPD52L1 | GSM4909281 | Human | Breast | IDC | 1.40e-02 | -2.37e-01 | 0.21 |
7164 | TPD52L1 | GSM4909286 | Human | Breast | IDC | 1.36e-06 | -3.13e-01 | 0.1081 |
7164 | TPD52L1 | GSM4909294 | Human | Breast | IDC | 3.71e-04 | -2.29e-01 | 0.2022 |
7164 | TPD52L1 | GSM4909296 | Human | Breast | IDC | 1.28e-11 | -3.70e-01 | 0.1524 |
7164 | TPD52L1 | GSM4909297 | Human | Breast | IDC | 7.69e-20 | -4.62e-01 | 0.1517 |
7164 | TPD52L1 | GSM4909301 | Human | Breast | IDC | 1.75e-15 | -4.22e-01 | 0.1577 |
7164 | TPD52L1 | GSM4909302 | Human | Breast | IDC | 2.71e-09 | -3.92e-01 | 0.1545 |
7164 | TPD52L1 | GSM4909308 | Human | Breast | IDC | 9.69e-09 | -3.58e-01 | 0.158 |
7164 | TPD52L1 | GSM4909311 | Human | Breast | IDC | 1.28e-28 | -4.35e-01 | 0.1534 |
7164 | TPD52L1 | GSM4909312 | Human | Breast | IDC | 2.76e-13 | -4.10e-01 | 0.1552 |
7164 | TPD52L1 | GSM4909315 | Human | Breast | IDC | 1.24e-04 | -3.36e-01 | 0.21 |
7164 | TPD52L1 | GSM4909319 | Human | Breast | IDC | 1.31e-32 | -5.60e-01 | 0.1563 |
7164 | TPD52L1 | GSM4909320 | Human | Breast | IDC | 4.60e-11 | -5.56e-01 | 0.1575 |
7164 | TPD52L1 | GSM4909321 | Human | Breast | IDC | 5.86e-20 | -4.06e-01 | 0.1559 |
7164 | TPD52L1 | ctrl6 | Human | Breast | Precancer | 4.30e-10 | -5.40e-01 | -0.0061 |
7164 | TPD52L1 | brca1 | Human | Breast | Precancer | 1.69e-07 | 3.41e-01 | -0.0338 |
7164 | TPD52L1 | brca10 | Human | Breast | Precancer | 1.99e-13 | -4.69e-01 | -0.0029 |
7164 | TPD52L1 | NCCBC14 | Human | Breast | DCIS | 8.85e-08 | -1.09e-01 | 0.2021 |
7164 | TPD52L1 | NCCBC2 | Human | Breast | DCIS | 1.15e-02 | -3.19e-01 | 0.1554 |
7164 | TPD52L1 | NCCBC3 | Human | Breast | DCIS | 3.67e-11 | -4.12e-01 | 0.1198 |
Page: 1 2 3 4 5 6 7 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:20012339 | Breast | Precancer | regulation of apoptotic signaling pathway | 65/1080 | 356/18723 | 7.70e-17 | 3.17e-14 | 65 |
GO:20012356 | Breast | Precancer | positive regulation of apoptotic signaling pathway | 24/1080 | 126/18723 | 1.98e-07 | 1.01e-05 | 24 |
GO:00336749 | Breast | Precancer | positive regulation of kinase activity | 42/1080 | 467/18723 | 2.94e-03 | 2.54e-02 | 42 |
GO:200123314 | Breast | IDC | regulation of apoptotic signaling pathway | 82/1434 | 356/18723 | 6.27e-20 | 5.93e-17 | 82 |
GO:200123514 | Breast | IDC | positive regulation of apoptotic signaling pathway | 31/1434 | 126/18723 | 4.13e-09 | 3.35e-07 | 31 |
GO:200123324 | Breast | DCIS | regulation of apoptotic signaling pathway | 81/1390 | 356/18723 | 3.51e-20 | 3.31e-17 | 81 |
GO:200123523 | Breast | DCIS | positive regulation of apoptotic signaling pathway | 31/1390 | 126/18723 | 1.96e-09 | 1.76e-07 | 31 |
GO:00447724 | Breast | DCIS | mitotic cell cycle phase transition | 46/1390 | 424/18723 | 6.16e-03 | 4.39e-02 | 46 |
GO:2001233111 | Esophagus | ESCC | regulation of apoptotic signaling pathway | 256/8552 | 356/18723 | 4.11e-24 | 1.04e-21 | 256 |
GO:004477216 | Esophagus | ESCC | mitotic cell cycle phase transition | 281/8552 | 424/18723 | 4.63e-18 | 4.45e-16 | 281 |
GO:007190016 | Esophagus | ESCC | regulation of protein serine/threonine kinase activity | 227/8552 | 359/18723 | 1.12e-11 | 4.10e-10 | 227 |
GO:2001235110 | Esophagus | ESCC | positive regulation of apoptotic signaling pathway | 92/8552 | 126/18723 | 3.91e-10 | 1.05e-08 | 92 |
GO:00448394 | Esophagus | ESCC | cell cycle G2/M phase transition | 103/8552 | 148/18723 | 3.09e-09 | 6.67e-08 | 103 |
GO:00000864 | Esophagus | ESCC | G2/M transition of mitotic cell cycle | 96/8552 | 137/18723 | 6.00e-09 | 1.23e-07 | 96 |
GO:003109818 | Esophagus | ESCC | stress-activated protein kinase signaling cascade | 154/8552 | 247/18723 | 8.53e-08 | 1.44e-06 | 154 |
GO:005140318 | Esophagus | ESCC | stress-activated MAPK cascade | 147/8552 | 239/18723 | 5.43e-07 | 7.18e-06 | 147 |
GO:00719029 | Esophagus | ESCC | positive regulation of protein serine/threonine kinase activity | 124/8552 | 200/18723 | 2.27e-06 | 2.61e-05 | 124 |
GO:004586018 | Esophagus | ESCC | positive regulation of protein kinase activity | 219/8552 | 386/18723 | 6.91e-06 | 6.97e-05 | 219 |
GO:003367420 | Esophagus | ESCC | positive regulation of kinase activity | 260/8552 | 467/18723 | 7.26e-06 | 7.22e-05 | 260 |
GO:007030217 | Esophagus | ESCC | regulation of stress-activated protein kinase signaling cascade | 119/8552 | 195/18723 | 1.07e-05 | 1.01e-04 | 119 |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TPD52L1 | SNV | Missense_Mutation | novel | c.219N>T | p.Met73Ile | p.M73I | protein_coding | tolerated(1) | benign(0.192) | TCGA-EO-A3AV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | CR | |
TPD52L1 | SNV | Missense_Mutation | novel | c.456N>A | p.Phe152Leu | p.F152L | protein_coding | deleterious(0) | probably_damaging(0.995) | TCGA-EO-A3B0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
TPD52L1 | SNV | Missense_Mutation | rs772348702 | c.514G>A | p.Gly172Ser | p.G172S | protein_coding | tolerated(0.08) | probably_damaging(1) | TCGA-EY-A549-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
TPD52L1 | SNV | Missense_Mutation | novel | c.197N>G | p.Glu66Gly | p.E66G | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-EY-A5W2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
TPD52L1 | SNV | Missense_Mutation | c.263N>G | p.His88Arg | p.H88R | protein_coding | tolerated(0.08) | probably_damaging(0.944) | TCGA-QS-A5YR-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | ||
TPD52L1 | SNV | Missense_Mutation | novel | c.571A>G | p.Ser191Gly | p.S191G | protein_coding | deleterious(0.04) | possibly_damaging(0.528) | TCGA-ZP-A9CV-01 | Liver | liver hepatocellular carcinoma | Male | <65 | I/II | Unknown | Unknown | PD | |
TPD52L1 | SNV | Missense_Mutation | c.384N>A | p.Met128Ile | p.M128I | protein_coding | deleterious(0.01) | benign(0.127) | TCGA-86-7955-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Chemotherapy | etoposide | PD | ||
TPD52L1 | insertion | Frame_Shift_Ins | novel | c.284_284+1insT | p.Tyr96LeufsTer6 | p.Y96Lfs*6 | protein_coding | TCGA-66-2765-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |||
TPD52L1 | deletion | Frame_Shift_Del | novel | c.231delN | p.Asn77LysfsTer3 | p.N77Kfs*3 | protein_coding | TCGA-KK-A7AY-01 | Prostate | prostate adenocarcinoma | Male | <65 | 7 | Unknown | Unknown | PD | |||
TPD52L1 | SNV | Missense_Mutation | novel | c.256A>C | p.Ser86Arg | p.S86R | protein_coding | deleterious(0.01) | possibly_damaging(0.655) | TCGA-BR-8680-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Chemotherapy | oxaliplatin | CR |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |